Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS

May.06
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.

Key Takeaways

  • Altria recorded first-quarter 2026 net revenues of $5.43 billion, up 3.2%.
  • Revenues net of excise taxes were $4.76 billion, up 5.3%.
  • Adjusted diluted EPS was $1.32, up 7.3%.
  • The company reaffirmed full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72.
  • Altria repurchased $280 million of shares and paid $1.8 billion in dividends during the quarter.

2Firsts, May 6, 2026 

 

According to Altria Group’s first-quarter 2026 earnings release, the company recorded net revenues of $5.43 billion, up 3.2% year on year. Revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, while adjusted diluted EPS was $1.32, up 7.3%.

 

Adjusted diluted EPS rose 7.3% in Q1

 

Altria Chief Executive Officer Billy Gifford said the company grew adjusted diluted EPS by 7.3% in the first quarter and returned capital to shareholders through dividends and share repurchases. 

 

The company said adjusted diluted EPS growth was driven by higher adjusted operating companies income and fewer shares outstanding.

 

Full-year earnings guidance was reaffirmed

 

Altria reaffirmed its expectation to deliver 2026 full-year adjusted diluted EPS in a range of $5.56 to $5.72, representing a growth rate of 2.5% to 5.5% from a base of $5.42 in 2025. 

 

The company said that, as a result of strong first-quarter performance, it now expects 2026 adjusted diluted EPS growth to be more balanced between the first and second halves of the year.

 

Guidance includes moderated e-vapor industry growth

 

Altria said its reaffirmed guidance range now contemplates the impact of moderated e-vapor industry growth on combustible and e-vapor product volumes, as well as increased macroeconomic uncertainty facing adult nicotine consumers. 

 

The guidance also contemplates a progressive increase in cigarette import and export activity during the year, planned investments in contract manufacturing capabilities, NJOY ACE not returning to the marketplace in 2026, reinvestment of anticipated cost savings from the Optimize & Accelerate initiative, and planned investments in support of the company’s Vision.

 

Smokeable products revenues net of excise taxes rose 5.2%

 

In the smokeable products segment, net revenues were $4.76 billion, up 2.9%, while revenues net of excise taxes were $4.11 billion, up 5.2%. Reported operating companies income was $2.67 billion, up 8.3%, and adjusted operating companies income was $2.68 billion, up 6.3%. Adjusted operating companies income margin was 65.1%, up 0.7 percentage points.

 

Domestic cigarette shipment volume declined 2.4%

 

Altria’s smokeable products segment reported domestic cigarette shipment volume of 13.87 billion sticks in the first quarter, down 2.4%. Marlboro shipment volume was 11.96 billion sticks, down 7.8%; other premium brands were 601 million sticks, down 11.4%; and discount brands were 1.31 billion sticks, up more than 100%. 

 

When adjusted for trade inventory movements, the company estimated that smokeable products domestic cigarette shipment volume decreased by 4%, while total domestic cigarette industry volume decreased by 5%.

 

Oral tobacco products revenue increased 2.3%

 

In the oral tobacco products segment, net revenues were $669 million, up 2.3%, while revenues net of excise taxes were $647 million, up 2.9%. Reported operating companies income was $435 million, up 0.5%, and adjusted operating companies income was $436 million, up 0.2%. Adjusted operating companies income margin was 67.4%, down 1.8 percentage points.

 

on! shipment volume increased 17.6%

 

The oral tobacco products segment reported domestic shipment volume of 169.9 million cans, down 3.1%. Copenhagen shipment volume was 80.4 million cans, down 10.4%; Skoal was 27.9 million cans, down 11.1%; and on! was 46.2 million cans, up 17.6%. 

 

Altria said the U.S. nicotine pouch category grew to 58.1% of the U.S. oral tobacco category for the six months ended March 31, 2026, up 9.1 percentage points year on year.

 

on! held a 7.8% share of the U.S. oral tobacco category

 

The total U.S. oral tobacco category share for on! nicotine pouches was 7.8%, down 0.8 percentage points from the prior year and up 0.2 points sequentially. on!’s share of the nicotine pouch category was 13.4%, down 4.2 percentage points year on year.

 

Altria repurchased $280 million of shares and paid $1.8 billion in dividends

 

In the first quarter of 2026, Altria repurchased 4.5 million shares at an average price of $62.33 per share, for a total cost of $280 million. 

 

As of March 31, 2026, the company had $720 million remaining under its $2 billion share repurchase program, which expires on December 31, 2026. The company paid $1.8 billion in dividends during the first quarter.

Image Source:Altria 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
The Texas Supreme Court issued a case summary on May 8, 2026, describing its decision in Hancock v. RJR Vapor Co. LLC. The dispute centered on whether RJR Vapor’s VELO oral nicotine pouches are taxable as “tobacco products” under the Texas Tax Code. Lower courts had held that the pouches were not taxable tobacco products, but the Texas Supreme Court reversed, concluding that VELO pouches are taxable because they are made of “a tobacco substitute.”
May.09 by 2FIRSTS.ai
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
British American Tobacco (BAT) CEO Tadeu Marroco said the U.S. unauthorized vape market is worth about £7 billion, or US$9.43 billion. Following a shift in FDA enforcement policy, BAT plans to launch flavored Vuse products in the third quarter and an updated Velo pouch in August or September.
Jun.15
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
ZYN ULTRA Expands Haypp’s U.S. E-Commerce Lineup With 9 mg Pouches
ZYN ULTRA Expands Haypp’s U.S. E-Commerce Lineup With 9 mg Pouches
Haypp Group said ZYN ULTRA became available nationwide in the United States on June 15 through its e-commerce platforms Nicokick.com and Northerner.com for verified adult nicotine consumers.
Jun.17